Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Cattran

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Transplantation Research|February 2, 2013
A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipientsEdward H Cole, G V Ramesh Prasad, Carl J Cardella, et al.
Plos One|August 19, 2014
The molecular phenotype of endocapillary proliferation: novel therapeutic targets for IgA nephropathyJeffrey B Hodgin, Celine C Berthier, Rohan John, et al.
JAMA Internal Medicine|April 14, 2019
Evaluating a New International Risk-Prediction Tool in IgA NephropathySean J Barbour, Rosanna Coppo, Hong Zhang, et al.
Kidney International|January 23, 2019
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceJürgen Floege, Sean J Barbour, Daniel C Cattran, et al.
Kidney International|January 22, 2026
A secondary analysis of the TESTING trial predicted individual patient response to corticosteroid treatment in IgA nephropathyMark Canney, Sana Shan, Lee Er, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 20, 2023
Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous NephropathySean J Barbour, Fernando C Fervenza, Dilshani Induruwage, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2012
Low- and high-molecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective studyMaria V Irazabal, Alfonso Eirin, John Lieske, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 15, 2011
Venous thromboembolism in patients with membranous nephropathySophia Lionaki, Vimal K Derebail, Susan L Hogan, et al.
Kidney International|March 1, 2016
Patients with primary membranous nephropathy are at high risk of cardiovascular eventsTaewoo Lee, Vimal K Derebail, Abhijit V Kshirsagar, et al.
Kidney International|November 21, 2020
Updating the International IgA Nephropathy Prediction Tool for use in childrenSean J Barbour, Rosanna Coppo, Lee Er, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Transplantation Research|February 2, 2013
A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipientsEdward H Cole, G V Ramesh Prasad, Carl J Cardella, et al.
Plos One|August 19, 2014
The molecular phenotype of endocapillary proliferation: novel therapeutic targets for IgA nephropathyJeffrey B Hodgin, Celine C Berthier, Rohan John, et al.
JAMA Internal Medicine|April 14, 2019
Evaluating a New International Risk-Prediction Tool in IgA NephropathySean J Barbour, Rosanna Coppo, Hong Zhang, et al.
Kidney International|January 23, 2019
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceJürgen Floege, Sean J Barbour, Daniel C Cattran, et al.
Kidney International|January 22, 2026
A secondary analysis of the TESTING trial predicted individual patient response to corticosteroid treatment in IgA nephropathyMark Canney, Sana Shan, Lee Er, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 20, 2023
Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous NephropathySean J Barbour, Fernando C Fervenza, Dilshani Induruwage, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2012
Low- and high-molecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective studyMaria V Irazabal, Alfonso Eirin, John Lieske, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 15, 2011
Venous thromboembolism in patients with membranous nephropathySophia Lionaki, Vimal K Derebail, Susan L Hogan, et al.
Kidney International|March 1, 2016
Patients with primary membranous nephropathy are at high risk of cardiovascular eventsTaewoo Lee, Vimal K Derebail, Abhijit V Kshirsagar, et al.
Kidney International|November 21, 2020
Updating the International IgA Nephropathy Prediction Tool for use in childrenSean J Barbour, Rosanna Coppo, Lee Er, et al.
Pageof 11